| 1.9 |
11.1 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 1.1 |
5.3 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 1.0 |
2.0 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) |
| 0.9 |
5.1 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.9 |
2.6 |
GO:0021577 |
hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
| 0.8 |
2.5 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
| 0.8 |
2.3 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 0.8 |
2.3 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.7 |
2.2 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.7 |
3.4 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.7 |
2.0 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.6 |
1.9 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.6 |
1.9 |
GO:0086017 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) Purkinje myocyte action potential(GO:0086017) |
| 0.6 |
5.0 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.6 |
1.9 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.6 |
1.8 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.6 |
2.9 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.5 |
1.6 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
| 0.5 |
3.1 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.5 |
1.0 |
GO:0002182 |
cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.5 |
0.5 |
GO:1904058 |
positive regulation of sensory perception of pain(GO:1904058) |
| 0.5 |
1.5 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.5 |
5.6 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.5 |
2.7 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.5 |
1.8 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.4 |
1.3 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.4 |
6.9 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.4 |
1.3 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.4 |
2.0 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.4 |
1.2 |
GO:0019405 |
alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.4 |
1.2 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.4 |
1.2 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.4 |
1.2 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.4 |
1.9 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.4 |
1.1 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.3 |
1.7 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.3 |
2.7 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.3 |
1.7 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.3 |
3.0 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.3 |
1.0 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 0.3 |
1.6 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.3 |
1.3 |
GO:0045759 |
negative regulation of action potential(GO:0045759) |
| 0.3 |
2.1 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.3 |
2.4 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.3 |
0.9 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.3 |
0.3 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.3 |
1.1 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.3 |
0.8 |
GO:0048162 |
preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
| 0.3 |
1.1 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.3 |
2.1 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.3 |
1.0 |
GO:0090238 |
positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.3 |
0.8 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.2 |
1.0 |
GO:0051311 |
meiotic metaphase plate congression(GO:0051311) |
| 0.2 |
1.9 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.2 |
4.1 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.2 |
0.7 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.2 |
1.9 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.2 |
0.7 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.2 |
0.7 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.2 |
1.1 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.2 |
0.7 |
GO:0017055 |
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.2 |
0.6 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
2.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.2 |
0.6 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.2 |
0.6 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.2 |
1.0 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 |
3.9 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.2 |
2.1 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
| 0.2 |
0.6 |
GO:0070428 |
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 0.2 |
0.2 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 |
1.8 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.2 |
0.7 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.2 |
0.7 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
2.9 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 |
1.4 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.2 |
0.9 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.2 |
0.5 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.2 |
2.6 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
0.5 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
0.2 |
GO:0010725 |
regulation of primitive erythrocyte differentiation(GO:0010725) |
| 0.2 |
1.4 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.2 |
0.5 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.2 |
0.8 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.2 |
0.6 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) histone H4-R3 methylation(GO:0043985) |
| 0.2 |
0.3 |
GO:0014735 |
regulation of muscle atrophy(GO:0014735) |
| 0.2 |
1.0 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.2 |
0.8 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 |
2.0 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
5.4 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.1 |
0.9 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
1.3 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.1 |
0.6 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.1 |
1.7 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.1 |
0.3 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.1 |
0.8 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.1 |
0.8 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.1 |
1.0 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.1 |
0.3 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.1 |
0.3 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
0.9 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.5 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 |
1.2 |
GO:0098907 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.1 |
0.8 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.1 |
1.1 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
0.5 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 |
1.3 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.1 |
0.6 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.1 |
0.6 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 |
2.8 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
1.4 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.1 |
0.2 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.1 |
0.8 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 |
0.2 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
1.1 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.1 |
1.3 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
0.7 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
1.0 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.5 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.1 |
0.3 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
1.2 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.1 |
1.6 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
2.2 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.3 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 |
0.7 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.7 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
4.3 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.4 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.1 |
1.0 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.5 |
GO:0033136 |
serine phosphorylation of STAT3 protein(GO:0033136) |
| 0.1 |
2.2 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.1 |
1.0 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.1 |
0.6 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.6 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.6 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 0.1 |
0.7 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.1 |
0.6 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.8 |
GO:0001956 |
positive regulation of neurotransmitter secretion(GO:0001956) |
| 0.1 |
0.3 |
GO:0030046 |
meiotic chromosome movement towards spindle pole(GO:0016344) parallel actin filament bundle assembly(GO:0030046) formin-nucleated actin cable assembly(GO:0070649) |
| 0.1 |
0.6 |
GO:0002072 |
optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
| 0.1 |
0.5 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.1 |
1.0 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
1.1 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.1 |
0.3 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.1 |
0.2 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 |
0.3 |
GO:1903753 |
negative regulation of p38MAPK cascade(GO:1903753) |
| 0.1 |
0.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.3 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.1 |
0.6 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
1.3 |
GO:0080111 |
DNA demethylation(GO:0080111) |
| 0.1 |
0.9 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
0.4 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
0.5 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 |
0.2 |
GO:1902608 |
testosterone biosynthetic process(GO:0061370) regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.1 |
0.5 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.2 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 0.1 |
0.5 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) macropinocytosis(GO:0044351) |
| 0.1 |
0.5 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.7 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 |
2.9 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.1 |
0.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.6 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.1 |
1.1 |
GO:1903861 |
regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.1 |
0.8 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.1 |
0.6 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
3.6 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.1 |
0.5 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.1 |
0.4 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.1 |
0.9 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.1 |
2.5 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.1 |
0.5 |
GO:0061577 |
calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.1 |
0.3 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
1.9 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.5 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.1 |
2.6 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.1 |
0.2 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.1 |
0.2 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.1 |
0.6 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.1 |
0.2 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.1 |
1.0 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.2 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.1 |
0.2 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.1 |
0.2 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 0.1 |
1.0 |
GO:0048741 |
skeletal muscle fiber development(GO:0048741) |
| 0.1 |
0.2 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.1 |
0.4 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
1.1 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.2 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.0 |
0.5 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.0 |
0.1 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.0 |
0.3 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.0 |
0.3 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.2 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.0 |
0.9 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.3 |
GO:0018377 |
N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
| 0.0 |
0.8 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
1.5 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.4 |
GO:0060510 |
Type II pneumocyte differentiation(GO:0060510) |
| 0.0 |
0.1 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.1 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.0 |
0.9 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.2 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) negative regulation of histone H3-K4 methylation(GO:0051572) specification of axis polarity(GO:0065001) |
| 0.0 |
0.8 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.0 |
0.6 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.0 |
0.5 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.0 |
0.7 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.0 |
1.3 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 |
0.3 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.0 |
1.2 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.0 |
0.2 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.0 |
0.3 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
0.9 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.1 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.0 |
0.3 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 |
0.5 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
1.2 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.6 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.4 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.0 |
0.5 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.0 |
0.7 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.3 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.0 |
0.3 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.2 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.8 |
GO:0030811 |
regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
| 0.0 |
0.1 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.0 |
0.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.5 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.1 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.0 |
0.3 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.0 |
0.7 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
2.0 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.0 |
0.0 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.0 |
0.1 |
GO:0060459 |
extraocular skeletal muscle development(GO:0002074) pulmonary myocardium development(GO:0003350) subthalamus development(GO:0021539) subthalamic nucleus development(GO:0021763) left lung development(GO:0060459) left lung morphogenesis(GO:0060460) pulmonary vein morphogenesis(GO:0060577) superior vena cava morphogenesis(GO:0060578) |
| 0.0 |
2.6 |
GO:0050821 |
protein stabilization(GO:0050821) |
| 0.0 |
0.1 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 |
0.3 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
0.2 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.0 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 0.0 |
0.4 |
GO:0043486 |
histone exchange(GO:0043486) |
| 0.0 |
1.0 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.0 |
1.2 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.4 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.8 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.0 |
0.3 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.0 |
0.9 |
GO:0030512 |
negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
| 0.0 |
0.4 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.0 |
0.3 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.2 |
GO:0046929 |
negative regulation of neurotransmitter secretion(GO:0046929) |
| 0.0 |
0.2 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.0 |
0.3 |
GO:0021702 |
cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 |
0.4 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.2 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.1 |
GO:0090050 |
positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 |
0.1 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.0 |
0.1 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.0 |
0.1 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.0 |
0.1 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.0 |
0.6 |
GO:1903363 |
negative regulation of cellular protein catabolic process(GO:1903363) |
| 0.0 |
0.4 |
GO:2000816 |
negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.0 |
0.3 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) |
| 0.0 |
0.5 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.0 |
0.3 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.0 |
1.9 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.0 |
0.4 |
GO:0006584 |
catecholamine metabolic process(GO:0006584) catechol-containing compound metabolic process(GO:0009712) |
| 0.0 |
0.7 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.0 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.0 |
0.1 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.0 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.2 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.2 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.0 |
0.4 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.1 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
2.4 |
GO:0051260 |
protein homooligomerization(GO:0051260) |
| 0.0 |
0.0 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.0 |
0.1 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.0 |
0.3 |
GO:0045851 |
pH reduction(GO:0045851) |
| 0.0 |
0.2 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
